PTC Therapeutics Inc (PTCT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $5.30B
Last updated: Nov 17, 2026 at 11:06 AM ET
PTC Therapeutics Inc (PTCT) Competitors
The companies most similar to PTC Therapeutics are Protagonist Therapeutics (PTGX), TG Therapeutics (TGTX) and Travere Therapeutics (TVTX). By market cap, PTC Therapeutics ranks 5th of the 13 companies on this page; TG Therapeutics (TGTX) is the largest at $9.75B. The median P/E of the 4 companies with a P/E is 63.8x.
Peer Comparison
PTCT's ROIC of 18.1% is above the peer median of -26.4%, and its revenue growth of 69.6% is above the median of 48.5%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| PTC Therapeutics (PTCT) | $5.30B | N/A | 5.2x | -9.2% | 18.1% | 69.6% | 0.00% |
| Protagonist Therapeutics Inc (PTGX) | $8.55B | 27.7x | 15.8x | 62.0% | N/A | 5724.0% | 0.00% |
| TG Therapeutics Inc (TGTX) | $9.75B | 87.2x | 11.1x | 11.8% | 11.0% | 60.7% | 0.00% |
| Travere Therapeutics Inc (TVTX) | $4.86B | N/A | 7.2x | -18.7% | -23.1% | 36.2% | 0.00% |
| Cogent Biosciences Inc (COGT) | $4.97B | N/A | N/A | 0.0% | -43.4% | -100.0% | 0.00% |
| Praxis Precision Medicines Inc (PRAX) | $9.17B | N/A | N/A | 0.0% | N/A | 1349.0% | 0.00% |
| Crispr Therapeutics AG (CRSP) | $4.10B | N/A | 155.2x | 0.0% | -20.3% | 1325.0% | 0.00% |
| Tarsus Pharmaceuticals Inc (TARS) | $3.96B | N/A | 5.4x | -102.9% | -393.6% | 63.9% | 0.00% |
| Dianthus Therapeutics Inc. (DNTH) | $5.17B | N/A | N/A | 0.0% | N/A | 205.6% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Krystal Biotech Inc (KRYS) | $9.05B | 40.4x | 18.8x | 47.9% | N/A | 30.2% | 0.00% |
| Palvella Therapeutics, Inc (PVLA) | $2.23B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| Peer median | $4.92B | 63.8x | 13.0x | 0.0% | -26.4% | 48.5% | 0.00% |
Similar Companies
These are the 12 companies most similar to PTC Therapeutics, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Protagonist Therapeutics Inc (PTGX) | Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address unmet medical... | PTGX competitors |
| TG Therapeutics Inc (TGTX) | TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development... | TGTX competitors |
| Travere Therapeutics Inc (TVTX) | Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification... | TVTX competitors |
| Cogent Biosciences Inc (COGT) | Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies to treat genetically defined diseases. | COGT competitors |
| Praxis Precision Medicines Inc (PRAX) | Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal... | PRAX competitors |
| Crispr Therapeutics AG (CRSP) | CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. | CRSP competitors |
| Tarsus Pharmaceuticals Inc (TARS) | Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new therapeutic candidates... | TARS competitors |
| Dianthus Therapeutics Inc. (DNTH) | Dianthus Therapeutics, Inc. is a clinical-stage biotechnology company that designs, develops... | DNTH competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Krystal Biotech Inc (KRYS) | Krystal Biotech, Inc., a clinical-stage biotechnology company, is dedicated to the field of redosable gene therapy to treat serious rare diseases in the United... | KRYS competitors |
| Palvella Therapeutics, Inc (PVLA) | Palvella Therapeutics, Inc. is an innovative biotechnology firm dedicated to developing transformative therapies for rare genetic disorders resulting from... | PVLA competitors |
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
Frequently Asked Questions About PTCT
Who are PTC Therapeutics' main competitors?
The companies most similar to PTC Therapeutics include Protagonist Therapeutics (PTGX), TG Therapeutics (TGTX), Travere Therapeutics (TVTX), Cogent Biosciences (COGT) and Praxis Precision Medicines (PRAX), listed from the closest match.
Who is PTC Therapeutics' biggest competitor?
TG Therapeutics (TGTX) is the largest of the similar companies at $9.75B; Protagonist Therapeutics (PTGX) is the closest match by business profile, size, sector and industry.
How does PTCT stock compare with its competitors?
PTCT's P/S is 5.2x against a peer median of 13.0x; its net margin is -9.2% against a peer median of 0.0%.
Which of PTC Therapeutics' competitors pays a higher dividend?
PTC Therapeutics pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is PTC Therapeutics bigger than its competitors?
No. PTC Therapeutics is 5th by market cap among the 13 companies on this page; the largest is TG Therapeutics (TGTX) at $9.75B.
PTCT pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors